ALIVIA TACKETT: Open Payments
NPI 1124797113 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,613 in 181 payments from 13 companies in 2025. Trend: 2023 $1,275 · 2024 $1,354 · 2025 $2,613
Food & beverage: $2,494Education: $119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $482 |
| Teva Pharmaceuticals USA, Inc. | 20 | $314 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $306 |
| Vanda Pharmaceuticals Inc. | 20 | $254 |
| Alkermes, Inc. | 13 | $247 |
| Axsome Therapeutics, Inc. | 9 | $239 |
| Otsuka America Pharmaceutical, Inc. | 20 | $222 |
| Neurocrine BioSciences, Inc. | 10 | $187 |
| E.R. Squibb & Sons, L.L.C. | 11 | $184 |
| Gilead Sciences, Inc. | 7 | $112 |
Products named: VRAYLAR, CAPLYTA, Auvelity, ARISTADA, INGREZZA, REXULTI, HETLIOZ, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
